在癌症中基于纳米材料的长非编码RNA的向:对当前趋势的前沿审查
Fatemeh Davodabadi1, Bahareh Farasati Far2, Saman Sargazi3,4
1Department of Biology, Faculty of Basic Science, Payame Noor University, Tehran, Iran.
ChemMedChem
|January 24, 2024
概括
纳米治疗策略在向癌症中长非编码RNA (lncRNAs) 方面表现有前途. 这些方法通过调节lncRNA的表达和功能来提高癌症诊断和治疗的有效性.
科学领域:
- 分子生物学分子生物学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 在癌症开始,进展和转移中发挥着关键作用.
- 在瘤学中,lncRNAs正在成为有价值的诊断生物标志物和治疗点.
- 调节lncRNA表达和功能为癌症治疗提供了一个有前途的途径.
研究的目的:
- 审查纳米治疗策略,以向癌细胞中的长非编码RNA (lncRNAs).
- 检查纳米载体在提供治疗药物的作用,以调节lncRNA活性.
- 突出 lncRNA 向纳米疗法在癌症诊断和治疗方面的潜力.
主要方法:
- 对针对 lncRNAs 的纳米治疗策略的当前文献的综述.
- 讨论基因调制技术,包括反感性寡核酸 (ASO),RNA干扰 (RNAi) 和基于CRISPR的基因编辑.
- 对纳米载体系统进行针对性药物输送在癌症治疗中的分析.
主要成果:
- 纳米治疗策略为针对各种癌症类型的lncRNA提供了有效的方法.
- 基于ASO,RNAi和CRISPR的工具是调制lncRNA功能的关键技术.
- 纳米载体通过向癌细胞输送药物,显著提高了向治疗的有效性.
结论:
- 用纳米治疗药物向lncRNA具有显著的希望,可以改善癌症诊断和治疗结果.
- 对lncRNA调节网络和功能相互作用的进一步研究对于完善纳米治疗策略至关重要.
- 本次审查强调了 lncRNAs 和纳米战略在推进癌症治疗中的重要作用.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K


